In our study of GBM tumor immune cycle and immune checkpoint blockade (ICB) response, we observed a significant positive correlation between ERG scores and ICB-related negative signals, as well as a positive correlation with the suppressive tumor immune cycle. This evidence concerns the gene ERG and glioblastoma.